Sickle cell diseases and ileus

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 9, 2014, Pages 2871-2876

  Helvaci, Mehmet Rami ^a   Aydogan, Akin ^a   Akkucuk, Seckin ^a   Oruc, Cem ^a   Ugur, Mustafa ^a  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

Author keywords

Atherosclerosis; Chronic endothelial damage; Ileus; Sickle cell diseases

Indexed keywords

ADOLESCENT; ADULT; ALCOHOL CONSUMPTION; ARTICLE; AVASCULAR NECROSIS; CEREBROVASCULAR ACCIDENT; CHILD; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CREATININE BLOOD LEVEL; DIGITAL CLUBBING; DISEASE MARKER; DOPPLER ECHOCARDIOGRAPHY; DOPPLER FLOWMETRY; ELECTROCARDIOGRAPHY; ERYTHROCYTE TRANSFUSION; FEMALE; FERRITIN BLOOD LEVEL; HEMATOCRIT; HEPATITIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ILEUS; IRON BINDING CAPACITY; IRON BLOOD LEVEL; ISCHEMIC HEART DISEASE; LEG ULCER; LEUKOCYTE COUNT; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PULMONARY HYPERTENSION; RHEUMATIC HEART DISEASE; SICKLE CELL ANEMIA; SMOKING; SYSTOLIC BLOOD PRESSURE; THALASSEMIA;

EID: 84907854946     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415-1428.
2. Helvaci MR, Kaya H, Borazan A, Ozer C, Seyhanli M, Yalcin A. Metformin and parameters of physical health. Intern Med 2008; 47: 697-703.
3. Helvaci MR, Aydin LY, Aydin Y. Chronic obstructive pulmonary disease may be one of the terminal end points of metabolic syndrome. Pak J Med Sci 2012; 28: 376-379.
4. Stojanovic OI, Lazovic M, Lazovic M, Vuceljic M. Association between atherosclerosis and osteoporosis, the role of vitamin D. Arch Med Sci 2011; 7: 179-188.
5. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease 2010. Global initiative for chronic obstructive lung disease (GOLD).
6. Fisher MR, Forfia PR, Chamera E, Housten-Harris T, Champion HC, Girgis RE, Corrretti MC, Hassoun PM. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med 2009; 179: 615-621.
7. Mankad VN, Williams JP, Harpen MD, Manci E, Longenecker G, Moore RB, Shah A, Yang YM, Brogdon BG. Magnetic resonance imaging of bone marrow in sickle cell disease: clinical, hematologic, and pathologic correlations. Blood 1990; 75: 274-283.
8. Schamroth L. Personal experience. S Afr Med J 1976; 50: 297-300.
9. Vandemergel X, Renneboog B. Prevalence, aetiologies and significance of clubbing in a department of general internal medicine. Eur J Intern Med 2008; 19: 325-329.
10. Krämer SC, Görich J, Oertel F, Scheld H, Heindel W. Non-occlusive mesenteric ischemia. Rofo 2003; 175: 1177-1183.
11. Reginelli A, Iacobellis F, Berritto D, Gagliardi G, Di Grezia G, Rossi M, Fonio P, Grassi R. Mesenteric ischemia: the importance of differential diagnosis for the surgeon. BMC Surg 2013; 13: 51.
12. Kurantsin-Mills J, Jacobs HM, Lessin LS. Sickle cell vaso-occlusion in an animal model; intravital microscopy and radionuclide imaging of selective sequestration of dense cells. Prog Clin Biol Res 1987; 240: 313-327.
13. Helvaci MR, Aydin Y, Ayyildiz O. Hydroxyurea may prolong survival of sickle cell patients by decreasing frequency of painful crises. HealthMED 2013; 7: 2327-2332.
14. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994; 330: 1639-1644.
15. Mathers CD, Sadana R, Salomon JA, Murray CJ, Lopez AD. Healthy life expectancy in 191 countries, 1999. Lancet 2001; 357: 1685-1691.
16. Helvaci MR, Ayyildiz O, Gundogdu M. Gender differences in severity of sickle cell diseases in non-smokers. Pak J Med Sci 2013; 29: 1050-1054.
17. Parfrey NA, Moore W, Hutchins GM. Is pain crisis a cause of death in sickle cell disease? Am J Clin Pathol 1985; 84: 209-212.
18. Helvaci MR, Gokce C. Painful crises and survival of sickle cell patients. HealthMED 2014; 8: 598-602.
19. Miller ST, Sleeper LA, Pegelow CH, Enos LE, Wang WC, Weiner SJ, Wethers DL, Smith J, Kinney TR. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med 2000; 342: 83-89.
20. Balkaran B, Char G, Morris JS, Thomas PW, Serjeant BE, Serjeant GR. Stroke in a cohort of patients with homozygous sickle cell disease. J Pediatr 1992; 120: 360-366.
21. Switzer JA, Hess DC, Nichols FT, Adams RJ. Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol 2006; 5: 501-512.
22. Gebreyohanns M, Adams RJ. Sickle cell disease: primary stroke prevention. CNS Spectr 2004; 9: 445-449.
23. Miller BA, Platt O, Hope S, Dover G, Nathan DG. Influence of hydroxyurea on fetal hemoglobin production in vitro. Blood 1987; 70: 1824-1829.
24. Charache S. Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults. Semin Hematol 1997; 34: 15-21.
25. Helvaci MR, Aydin Y, Gundogdu M. Smoking induced atherosclerosis in cancers. HealthMED 2012; 6: 3744-3749.
26. Fodor JG, Tzerovska R, Dorner T, Rieder A. Do we diagnose and treat coronary heart disease differently in men and women? Wien Med Wochenschr 2004; 154: 423-425.
27. Grunberg NE, Greenwood MR, Collins F, Epstein LH, Hatsukami D, Niaura R, et al. National working conference on smoking and body weight. Task Force 1: Mechanisms relevant to the relations between cigarette smoking and body weight. Health Psychol 1992; 11: 4-9.
28. Walker JF, Collins LC, Rowell PP, Goldsmith LJ, Moffatt RJ, Stamford BA. The effect of smoking on energy expenditure and plasma catecholamine and nicotine levels during light physical activity. Nicotine Tob Res 1999; 1: 365-370.
29. Hughes JR, Hatsukami DK. Effects of three doses of transdermal nicotine on post-cessation eating, hunger and weight. J Subst Abuse 1997; 9: 151-159.
30. Miyata G, Meguid MM, Varma M, Fetissov SO, Kim HJ. Nicotine alters the usual reciprocity between meal size and meal number in female rat. Physiol Behav 2001; 74: 169-176.
31. Laaksonen M, Rahkonen O, Prattala R. Smoking status and relative weight by educational level in Finland, 1978-1995. Prev Med 1998; 27: 431-437.
32. Froom P, Melamed S, Benbassat J. Smoking cessation and weight gain. J Fam Pract 1998; 46: 460-464.
33. Prescott E, Hippe M, Schnohr P, Hein HO, Vestbo J. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ 1998; 316: 1043-1047.
34. Helvaci MR, Kaya H, Gundogdu M. Association of increased triglyceride levels in metabolic syndrome with coronary artery disease. Pak J Med Sci 2010; 26: 667-672.